AA
ALPS Advisors Portfolio holdings
AUM
$17.3B
1-Year Return
13.43%
This Quarter Return
-11.26%
1 Year Return
+13.43%
3 Year Return
+69.62%
5 Year Return
+161.48%
10 Year Return
+94.79%
AUM
$10.3B
AUM Growth
+$1.07B
(+12%)
Cap. Flow
+$2.16B
Cap. Flow
% of AUM
21.03%
Top 10 Holdings %
Top 10 Hldgs %
47.42%
Holding
1,109
New
276
Increased
252
Reduced
500
Closed
79
Top Buys
| 1 |
Western Midstream Partners
WES
|
$588M |
| 2 |
Cameco
CCJ
|
$122M |
| 3 |
Hess Midstream
HESM
|
$73.2M |
| 4 |
Verizon
VZ
|
$58.8M |
| 5 |
Microsoft
MSFT
|
$48.4M |
Top Sells
| 1 |
Energy Transfer Partners
ET
|
$63.3M |
| 2 |
Enterprise Products Partners
EPD
|
$28.1M |
| 3 |
PBCT
People's United Financial Inc
PBCT
|
$23.8M |
| 4 |
REGI
Renewable Energy Group, Inc.
REGI
|
$20.4M |
| 5 |
ENLC
ENLINK MIDSTREAM, LLC
ENLC
|
$14.2M |
Sector Composition
| 1 | Energy | 60.43% |
| 2 | Technology | 6.16% |
| 3 | Healthcare | 4.82% |
| 4 | Consumer Discretionary | 4.16% |
| 5 | Industrials | 3.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Viridian Therapeutics
VRDN
$1.52B
| $192K | ﹤0.01% |
+16,560
| New | +$192K |
|
1002
Transocean
RIG
$2.92B
| $191K | ﹤0.01% |
+57,475
| New | +$191K |
|
1003
Seres Therapeutics
MCRB
$165M
| $188K | ﹤0.01% |
2,736
-1,993
| -42% | -$137K |
|
1004
MoonLake Immunotherapeutics
MLTX
$3.79B
| $164K | ﹤0.01% |
+31,260
| New | +$164K |
|
|
ADAP
1005
Adaptimmune Therapeutics
ADAP
$13.5M
| $163K | ﹤0.01% |
+96,110
| New | +$163K |
|
|
AUTL
1006
Autolus Therapeutics
AUTL
$386M
| $153K | ﹤0.01% |
53,931
-39,502
| -42% | -$112K |
|
|
WHWK
1007
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.3M
| $153K | ﹤0.01% |
12,423
-9,046
| -42% | -$111K |
|
1008
Archrock
AROC
$4.47B
| $152K | ﹤0.01% |
18,398
+2,310
| +14% | +$19.1K |
|
|
KLRS
1009
Kalaris Therapeutics, Inc. Common Stock
KLRS
$87.2M
| $151K | ﹤0.01% |
1,687
-1,233
| -42% | -$110K |
|
1010
SunCoke Energy
SXC
$644M
| $145K | ﹤0.01% |
21,348
+2,153
| +11% | +$14.6K |
|
1011
Rallybio
RLYB
$24.5M
| $144K | ﹤0.01% |
+19,060
| New | +$144K |
|
1012
CoreCivic
CXW
$2.13B
| $143K | ﹤0.01% |
12,906
+1,658
| +15% | +$18.4K |
|
1013
KalVista Pharmaceuticals
KALV
$765M
| $143K | ﹤0.01% |
14,561
-10,658
| -42% | -$105K |
|
|
LIAN
1014
DELISTED
LianBio American Depositary Shares
LIAN
| $139K | ﹤0.01% |
64,228
-45,991
| -42% | -$99.5K |
|
1015
Aldeyra Therapeutics
ALDX
$332M
| $138K | ﹤0.01% |
34,581
-25,125
| -42% | -$100K |
|
|
ICVX
1016
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $135K | ﹤0.01% |
+23,565
| New | +$135K |
|
1017
EverQuote
EVER
$869M
| $134K | ﹤0.01% |
+15,169
| New | +$134K |
|
1018
4D Molecular Therapeutics
FDMT
$309M
| $134K | ﹤0.01% |
+19,155
| New | +$134K |
|
1019
Zynex
ZYXI
$45.1M
| $127K | ﹤0.01% |
+15,855
| New | +$127K |
|
|
VBIV
1020
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $124K | ﹤0.01% |
+5,107
| New | +$124K |
|
|
KRON
1021
DELISTED
Kronos Bio
KRON
| $122K | ﹤0.01% |
33,651
-24,525
| -42% | -$88.9K |
|
1022
Kearny Financial
KRNY
$421M
| $116K | ﹤0.01% |
+10,414
| New | +$116K |
|
1023
Rigel Pharmaceuticals
RIGL
$720M
| $115K | ﹤0.01% |
10,207
-7,438
| -42% | -$83.8K |
|
1024
Acco Brands
ACCO
$363M
| $112K | ﹤0.01% |
17,090
+2,736
| +19% | +$17.9K |
|
|
CNCE
1025
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $112K | ﹤0.01% |
+26,665
| New | +$112K |
|